Research & Development
Valneva secures USD32m IXIARO vaccine contract with US DoD
25 September 2023 - Vaccine company Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) announced on Monday that it has signed a new contract valued at a minimum of USD32m with the US Department of Defense ...
Sanofi's ALTUVIIIO gains Japanese approval as haemophilia A factor VIII therapy
25 September 2023 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) said on Monday that the Japanese Ministry of Health, Labor and Welfare (MHLW) has granted marketing authoris...
MicuRx Pharmaceuticals' Contezolid and Contezolid acefosamil receive Fast Track Designation and US FDA QIDP
25 September 2023 - MicuRx Pharmaceuticals, Inc., a US-based biopharmaceutical company, announced on Friday that it has received Qualified Infectious Disease Product (QIDP) and Fast Track Designation ...
Seagen and Astellas Pharma report positive outcomes in advanced bladder cancer trial
...
Mabwell's 9MW3011 receives US FDA Fast Track Designation
22 September 2023 - Mabwell (688062.SH), a China-based biopharmaceutical company, announced on Thursday that it has received Fast Track Designation (FTD) from the US FDA for 9MW3011 (R&D code in t...
89bio receives FDA Breakthrough Therapy Designation for pegozafermin in NASH treatment
21 September 2023 - Clinical-stage biopharmaceutical company 89bio Inc (Nasdaq:ETNB) announced on Thursday that it has been granted Breakthrough Therapy Designation (BTD) by the US Food and Drug Admin...